 |
인쇄하기
취소
|
Hanmi wins Korean patent for antineoplastic composition
Hanmi Pharm said Thursday that it acquired a Korean patent for a composition that may safely extend the expiration date of a target anticancer drug up to a couple of years.
The title of this invention is “Pharmaceutical composition containing amide derivative and its pharmaceutically acceptable salt.”
The patent is characterized by adding an acidic stabilizer to a target anticancer agent ...
The title of this invention is “Pharmaceutical composition containing amide derivative and its pharmaceutically acceptable salt.”
The patent is characterized by adding an acidic stabilizer to a target anticancer agent ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.